Valuation: Medpace Holdings, Inc.

Market Cap 18.27B 16.39B 14.97B 13.67B 25.75B 1,717B 26.57B 180B 71.97B 916B 68.57B 67.1B 2,893B P/E 2026 *
35.8x
P/E 2027 * 33.3x
Enterprise Value 17.46B 15.66B 14.31B 13.06B 24.61B 1,641B 25.39B 172B 68.77B 876B 65.52B 64.12B 2,764B EV / Sales 2026 *
6.13x
EV / Sales 2027 * 5.63x
Free-Float
81.14%
Yield 2026 *
-
Yield 2027 * -
1 day+2.86%
1 week+0.17%
Current month+0.17%
1 month+8.33%
3 months+11.64%
6 months+53.03%
Current year+16.28%
1 week 632.11
Extreme 632.11
676.68
1 month 590.46
Extreme 590.455
693.97
Current year 373
Extreme 373
693.97
1 year 373
Extreme 373
693.97
3 years 250.05
Extreme 250.05
693.97
5 years 126.94
Extreme 126.945
693.97
10 years 21.76
Extreme 21.76
693.97
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
10/12/26 A Exercice

Chief Operating Officer

6,000 0.0215%
10/7/26 A Exercice

Chief Operating Officer

4,000 0.0143%
9/30/26 A Sell

Chief Executive Officer

-21,966 0.0787%
Change 5-day change 1-year change 3-year change Capi.($)
+2.86%+0.17%+10.29%+142.46% 18.27B
-4.83%+3.51%+53.62%+61.75% 65.94B
-1.34%+2.98%+24.79%+100.18% 56.53B
+0.02%+1.07%+10.63%+76.66% 56.88B
+5.09%+9.89%+22.45%+107.48% 46.49B
+2.62%+1.68%+28.91%+37.01% 44.8B
+8.24%+0.51%+213.26%+792.66% 41.59B
-1.86%+10.13%+26.82%+53.22% 35.35B
-2.97%-9.84%+88.86%+76.17% 33.29B
-2.18%+7.06%+36.06%-4.95% 24.92B
Average +0.57%+2.94%+51.57%+144.27% 42.41B
Weighted average by Cap. +0.32%+3.26%+51.27%+142.93%

Financials

2026 *2027 *
Net sales 2.85B 2.56B 2.34B 2.13B 4.02B 268B 4.14B 28.15B 11.23B 143B 10.7B 10.47B 451B 3.02B 2.71B 2.48B 2.26B 4.26B 284B 4.39B 29.85B 11.9B 152B 11.34B 11.1B 478B
Net income 521M 467M 427M 389M 734M 48.93B 757M 5.14B 2.05B 26.11B 1.95B 1.91B 82.42B 554M 497M 454M 414M 781M 52.05B 805M 5.47B 2.18B 27.78B 2.08B 2.03B 87.68B
Net Debt -812M -728M -665M -607M -1.14B -76.3B -1.18B -8.02B -3.2B -40.71B -3.05B -2.98B -129B -1.27B -1.14B -1.04B -952M -1.79B -120B -1.85B -12.57B -5.01B -63.81B -4.78B -4.67B -201B
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,600
Date Price Change Volume
06/11/26 $653.11 +2.86% 231,625
05/11/26 $634.98 -3.32% 315,868
04/11/26 $656.77 -1.01% 232,664
03/11/26 $663.49 +2.37% 229,526
02/11/26 $648.14 -0.59% 198,727
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
653.11USD
Average target price
651.31USD
Spread / Average Target
-0.28%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medpace Holdings, Inc.
  1. Stock Market
  2. Stocks
  3. MEDP Stock